File:Human embryo The molecular pathways involved in LEC differentiation from embryonic progenitors..jpg
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
Size of this preview: 702 × 599 pixels. Other resolutions: 281 × 240 pixels | 562 × 480 pixels | 899 × 768 pixels | 1,199 × 1,024 pixels | 2,211 × 1,888 pixels.
Original file (2,211 × 1,888 pixels, file size: 1.31 MB, MIME type: image/jpeg)
File information
Structured data
Captions
Summary[edit]
DescriptionHuman embryo The molecular pathways involved in LEC differentiation from embryonic progenitors..jpg | Figure 2. The molecular pathways involved in LEC differentiation from embryonic progenitors. (1) The mmp13b-par1-gnai2a axis activates VEGF-C/VEGFR3/ERK1/2 signaling through HHEX, which induces Prox1 expression and promotes the lymphangiogenesis; (2) Prox1, COUP-TFII, and SOX18 synchronously bind to the endogenous cyclin E1 promoter and interact with the differentiation and maintenance of LEC feature; (3) The expression of p53, p21, and p27 significantly promote the lymphatic sprouting in response to VEGF-C/VEGFR3 stimulation; (4) Dll4/NOTCH1/NOTCH4 axis regulates the expression of VEGFR3 via EphrinB2/Ras/MAPK signaling pathways; (5) The inhibitory splicing program Nova2 and effector Yap1, respectively, suppress or promote VEGFR3/ERK signaling pathway; (6) MAFB or Etv2 directly regulates the Prox1 and Flt4 expression; (7) miR-126a/Cxcl12a and VEGF-C/Flt4 signaling pathways cooperate and jointly direct LECs sprouting and extension. LEC: lymphatic endothelial cell. |
Date | |
Source | https://www.mdpi.com/cells/cells-11-04056/article_deploy/html/images/cells-11-04056-g002.png https://doi.org/10.3390/cells11244056 The Impact of Stem/Progenitor Cells on Lymphangiogenesis in Vascular Disease. Cells 2022, 11, 4056. |
Author | Mou, R.; Chen, K.; Zhu, P.; Xu, Q.; Ma, L. |
This file, which was originally posted to an external website, has not yet been reviewed by an administrator or reviewer to confirm that the above license is valid. See Category:License review needed for further instructions.
|
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Licensing[edit]
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 10:30, 26 April 2024 | 2,211 × 1,888 (1.31 MB) | Rasbak (talk | contribs) | == {{int:filedesc}} == {{Information |description=Figure 2. The molecular pathways involved in LEC differentiation from embryonic progenitors. (1) The mmp13b-par1-gnai2a axis activates VEGF-C/VEGFR3/ERK1/2 signaling through HHEX, which induces Prox1 expression and promotes the lymphangiogenesis; (2) Prox1, COUP-TFII, and SOX18 synchronously bind to the endogenous cyclin E1 promoter and interact with the differentiation and maintenance of LEC feature; (3) The expression of p53, p21, and p27 si... |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.